Tumor immune dysfunction and exclusion

2 papers study it3 more mention it1 finding

In silico2

Associations

1

Senescence-risk signature

downin silico1

1 study

Senescence-risk signature is associated with tumor immune dysfunction and exclusion in silico.
“whereas negatively correlated with tumor immune dysfunction and exclusion (TIDE)”
In silicoprostate cancer patients
Identification of a novel senescence-associated signature to predict biochemical recurrence and immune microenvironment for prostate cancer
Frontiers in immunologyFeb 20, 2023

More on Senescence-risk signature

Latest

Journal of CancerApr 5

Machine Learning-based Development and Validation of a Cell Senescence Predictive and Prognostic Signature in Intrahepatic Cholangiocarcinoma

Computational studyBiomarkers

Research SquareJan 19

Single-cell RNA sequencing reveals cellular senescence functions as a prognostic and therapeutic indicator in meningiomas

Preprint: computational studyCellular senescence

Frontiers in ImmunologyMar 10

Identification of a novel senescence-associated signature to predict biochemical recurrence and immune microenvironment for prostate cancer

Computational studyProstate cancer

Scientific ReportsJan 21

Cellular senescence affects energy metabolism, immune infiltration and immunotherapeutic response in hepatocellular carcinoma

Computational studyHepatocellular carcinoma

Frontiers in Molecular BiosciencesJan 3

Characterization of cellular senescence patterns predicts the prognosis and therapeutic response of hepatocellular carcinoma

Computational studyHepatocellular carcinoma